19 results on '"Skin Neoplasm"'
Search Results
2. Review of the comparative pathological and immunohistochemical features of human and canine cutaneous melanocytic neoplasms.
- Author
-
Contel IJ, Fonseca-Alves CE, Ferrari HF, Laufer-Amorim R, and Xavier-Júnior JCC
- Subjects
- Dogs, Animals, Humans, Biomarkers, Tumor, Melanoma, Cutaneous Malignant, Skin Neoplasms veterinary, Skin Neoplasms pathology, Dog Diseases pathology, Melanoma veterinary, Melanoma pathology, Immunohistochemistry
- Abstract
Melanocytic neoplasms originate from melanocytes and melanoma, the malignant form, is a common canine neoplasm and the most aggressive human skin cancer. Despite many similarities between these neoplasms in both species, only a limited number of studies have approached these entities in a comparative manner. Therefore, this review compares benign and malignant melanocytic neoplasms in dogs and humans, exclusively those arising in the haired skin, with regard to their clinicopathological, immunohistochemical and molecular aspects. Shared features include spontaneous occurrence, macroscopic features and microscopic findings when comparing human skin melanoma in the advanced/invasive stage and canine cutaneous melanoma, immunohistochemical markers and several histopathological prognostic factors. Differences include the apparent absence of active mutations in the BRAF gene in canine cutaneous melanoma and less aggressive clinical behaviour in dogs than in humans. Further studies are required to elucidate the aetiology and genetic development pathways of canine cutaneous melanocytic neoplasms. Evaluation of the applicability of histopathological prognostic parameters commonly used in humans for dogs are also needed. The similarities between the species and the recent findings regarding genetic mutations in canine cutaneous melanomas suggest the potential utility of dogs as a natural model for human melanomas that are not related to ultraviolet radiation., Competing Interests: Declaration of competing interests The authors declared no conflicts of interest in relation to the research, authorship and/or publication of this article., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Relationship between the inflammatory infiltrate and the degree of differentiation of the canine cutaneous squamous cell carcinoma
- Author
-
Clarissa Helena Santana, Pamela Rodrigues Reina Moreira, Mayara Caroline Rosolem, and Rosemeri de Oliveira Vasconcelos
- Subjects
Skin neoplasm ,Inflammation ,Lymphocytes ,Macrophages ,Plasma cells ,Immunohistochemistry ,Veterinary medicine ,SF600-1100 - Abstract
The inflammatory response may have pro or anti-neoplastic effects in tumors, depending on the histological type and malignancy level of the tumor. This study aimed to evaluate the profile of predominant inflammatory cells by immunohistochemistry in cutaneus squamous cell carcinoma (SCC) of dogs, comparing it with the degree of differentiation of the tumor. Twenty samples of SCC were analyzed. The tumors were histologically classified into two groups, differentiated SCC (SCCd=12) and undifferentiated SCC (SCCu=08). The tumor inflammatory infiltrate was determined by immunohistochemistry, in order to identify macrophages, lymphocytes and plasma cells. The comparison between groups, SCCd and SCCu, was not significant concerning the density of macrophages (P=1.0), T lymphocytes (P=0.335) and plasma cells (P=0.075). However, when comparing the inflammatory infiltrate in each group, the macrophages were the predominant cell type in both groups, a significant difference was found in the SCCd with plasma cells (P
- Published
- 2016
- Full Text
- View/download PDF
4. Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the Literature
- Author
-
Ethan James Harris, Tom Thomas, Allen C. Lam, Nicole G. Chau, Roy B. Tishler, Grace M. Lee, Daniel Wonsoon Kim, and Miranda B. Lam
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,medicine.medical_specialty ,lcsh:R895-920 ,Locally advanced ,Asymptomatic ,lcsh:RC254-282 ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Radiology, Nuclear Medicine and imaging ,Nose ,Microcystic adnexal carcinoma ,Philtrum ,Skin Neoplasm ,business.industry ,Teaching Case ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Nonsurgical treatment ,Carboplatin ,medicine.anatomical_structure ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Radiology ,medicine.symptom ,business - Abstract
Background Microcystic adnexal carcinoma (MAC) is a rare, locally invasive skin neoplasm most commonly in the head and neck. MAC is routinely treated surgically and scant data is available regarding the role of definitive chemoradiotherapy (chemoRT) as a surgical alternative. Methods A single case of MAC treated with upfront chemoRT is presented along with a review of the literature. Results A 73-year old man with locally advanced MAC of the philtrum and nose declined surgery and was treated with concurrent intensity-modulated RT (70Gy) and paclitaxel/carboplatin. His tumor responded clinically within two weeks of treatment. Partial radiographic response was observed at three months with improvement up to one year post-treatment. He remains asymptomatic and progression-free six years from the completion of his treatment. Conclusion Definitive chemoRT may be a nonsurgical treatment alternative for MAC when surgery is not possible or declined.
- Published
- 2020
5. Challenges in staging and surveillance of patients with neurofibromatosis and cutaneous malignant melanoma
- Author
-
P.R. Chew, V.V. Toh, and A. Kotwal
- Subjects
medicine.medical_specialty ,Staging ,Positron emission tomography-computed tomography ,lcsh:Surgery ,030230 surgery ,Breslow Thickness ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Neurofibromatosis ,Neurofibromatoses ,Skin Neoplasm ,medicine.diagnostic_test ,integumentary system ,Malignant melanoma ,business.industry ,Melanoma ,Incidence (epidemiology) ,Case Reports and Short Communication ,lcsh:RD1-811 ,medicine.disease ,Positron emission tomography ,030220 oncology & carcinogenesis ,Surgery ,Radiology ,Neurofibromatosis Type 1 ,Skin cancer ,business - Abstract
Summary: Malignant melanoma is a skin neoplasm with a rising trend of incidence. Positron Emission Tomography in combination with Computed Tomography (PET-CT) imaging is an essential diagnostic tool for both staging and surveillance of melanoma patients; especially in metastatic disease, where prognosis is poor. We report a case of a patient with known Neurofibromatosis type 1 (NF-1) who presented to the Skin Cancer Multidisciplinary meeting with 11 mm Breslow thickness malignant melanoma of the left forearm. His extensive dermal neurofibromatoses proved a diagnostic challenge to the team. There have been published studies linking NF-1 with malignant melanoma. However the incidence and significance of this has yet to be established. We also discuss the use of PET-CT imaging and skin surveillance in the monitoring and staging of this patient. Keywords: Malignant melanoma, Neurofibromatosis Type 1, Positron emission tomography-computed tomography, Staging
- Published
- 2019
6. Infiltrative squamous cell carcinoma in hidradenitis suppurativa: A case report for early surgical intervention
- Author
-
Yanjie Qi, Peter G. Juviler, and Ankit P. Patel
- Subjects
medicine.medical_specialty ,Fatal outcome ,Article ,Malignant transformation ,Pathogenesis ,03 medical and health sciences ,High morbidity ,0302 clinical medicine ,Dermis ,Squamous cell carcinoma ,Occlusion ,medicine ,Hidradenitis suppurativa ,Basal cell ,Skin neoplasm ,Skin Neoplasm ,business.industry ,medicine.disease ,Dermatology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Surgical management ,030211 gastroenterology & hepatology ,Surgery ,business - Abstract
Highlights • Hidradenitis suppurativa is a morbid disease and can resist medical management. • Squamous cell carcinoma may develop within a chronic hidradenitis suppurativa lesion. • Early surgical intervention with skin grafting offers relief from disease morbidly. • Early skin grafting eliminates risk of untreatable cancer discovery., Introduction Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the skin that has potential for malignant transformation into squamous cell carcinoma (SCC). The pathogenesis of HS is poorly understood but thought to be from follicular keratinization, occlusion, and rupture of the pilosebaceous unit, followed by an infiltration of inflammatory cells into the dermis. Treatment is challenging due to a lack of effective medical therapies. Presentation of case In this case report, we describe a patient with chronic HS that developed into SCC who underwent late surgical intervention after failing medical management. At the time malignant transformation was discovered, the SCC was beyond resectability and ultimately fatal. Discussion Based on the morbidity and mortality of chronic HS illustrated in our case and presented in the literature, we advocate for early surgical intervention. Conclusion Wide surgical excision offers a near definitive intervention and should at least be considered for all chronic HS patients due to high morbidity and malignant transformation risk.
- Published
- 2019
7. The relationship between menopausal hormone therapy and keratinocyte carcinoma: A review☆
- Author
-
Amanda R. Twigg, Raagini Suresh, and Jenny E. Murase
- Subjects
Oncology ,squamous cell carcinoma ,medicine.medical_specialty ,menopausal hormone therapy ,Context (language use) ,Dermatology ,Malignancy ,Article ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,basal cell carcinoma ,Internal medicine ,medicine ,Carcinoma ,Basal cell carcinoma ,Risk factor ,skin neoplasm ,Skin Neoplasm ,business.industry ,medicine.disease ,Increased risk ,030220 oncology & carcinogenesis ,RL1-803 ,Menopausal hormone therapy ,business ,keratinocyte carcinoma - Abstract
Introduction: Keratinocyte carcinoma (KC) is the most common malignancy in the United States. The two most common forms of KC are basal cell carcinoma and squamous cell carcinoma (SCC), which account for 80% and 20% of cases, respectively. Objective: There are many well-established risk factors for KC, but a more controversial risk factor for KC development is menopausal hormone therapy (MHT). This review synthesizes existing information on this topic and identifies knowledge gaps for future study. Methods: A systematic review of the literature using the Medical Subject Headings terms “menopausal hormone therapy; skin neoplasms” was conducted in the PubMed database from March 19, 2018 to April 1, 2018. This yielded 168 articles, case reports, and reviews, which were further refined for inclusion during the development of this manuscript. Additional articles were identified from cited references. Results: Four studies pertaining to this topic were identified. The results were evaluated in the context of these studies’ strengths and weaknesses. MHT contributes to an increased risk of basal cell carcinoma in Caucasian subjects and may make these tumors histologically more aggressive. There is not enough evidence to make a conclusion with regard to a potential relationship between MHT and SCC. However, one study suggested an increased risk of SCC with MHT use and another demonstrated a temporal association with prolonged MHT use and increased risk of SCC development. Conclusion: Ever users of MHT should be screened more frequently for KC. This issue is of importance to dermatologists because patients who receive earlier diagnoses of KC will have a better opportunity to pursue treatment. Keywords: menopausal hormone therapy, skin neoplasm, basal cell carcinoma, squamous cell carcinoma, keratinocyte carcinoma
- Published
- 2018
8. An enlarging, ulcerated scalp nodule
- Author
-
Ladan Afifi, Jeffrey P. North, and Kanade Shinkai
- Subjects
SCC - Squamous cell carcinoma ,Pathology ,medicine.medical_specialty ,Hodgkin disease ,lymphoma ,Dermatology ,Article ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,lcsh:Dermatology ,Medicine ,HL, Hodgkin Lymphoma ,skin neoplasm ,ulcer ,Skin Neoplasm ,integumentary system ,business.industry ,Nodule (medicine) ,lcsh:RL1-803 ,medicine.disease ,PG, Pyoderma gangrenosum ,Lymphoma ,medicine.anatomical_structure ,Reed–Sternberg cell ,030220 oncology & carcinogenesis ,Scalp ,Reed-Sternberg cells ,SCC, Squamous cell carcinoma ,Hodgkin lymphoma ,medicine.symptom ,business ,Pyoderma gangrenosum ,B lymphocytes - Published
- 2018
9. Lock-in thermal imaging for the early-stage detection of cutaneous melanoma : a feasibility study
- Abstract
This paper theoretically evaluates lock-in thermal imaging for the early-stage detection of cutaneous melanoma. Lock-in thermal imaging is based on the periodic thermal excitation of the specimen under test. Resulting surface temperature oscillations are recorded with an infrared camera and allow the detection of variations of the sample's thermophysical properties under the surface. In this paper, the steady-state and transient skin surface temperatures are numerically derived for a different stage of development of the melanoma lesion using a two-dimensional axisymmetric multilayer heat-transfer model. The transient skin surface temperature signals are demodulated according to the digital lock-in principle to compute both a phase and an amplitude image of the lesions. The phase image can be advantageously used to accurately detect cutaneous melanoma at an early stage of development while the maximal phase shift can give precious information about the lesion invasion depth. The ability of lock-in thermal imaging to suppress disturbing subcutaneous thermal signals is demonstrated. The method is compared with the previously proposed pulse-based approaches, and the influence of the modulation frequency is further discussed.
- Published
- 2018
10. Lock-in thermal imaging for the early-stage detection of cutaneous melanoma : a feasibility study
- Abstract
This paper theoretically evaluates lock-in thermal imaging for the early-stage detection of cutaneous melanoma. Lock-in thermal imaging is based on the periodic thermal excitation of the specimen under test. Resulting surface temperature oscillations are recorded with an infrared camera and allow the detection of variations of the sample's thermophysical properties under the surface. In this paper, the steady-state and transient skin surface temperatures are numerically derived for a different stage of development of the melanoma lesion using a two-dimensional axisymmetric multilayer heat-transfer model. The transient skin surface temperature signals are demodulated according to the digital lock-in principle to compute both a phase and an amplitude image of the lesions. The phase image can be advantageously used to accurately detect cutaneous melanoma at an early stage of development while the maximal phase shift can give precious information about the lesion invasion depth. The ability of lock-in thermal imaging to suppress disturbing subcutaneous thermal signals is demonstrated. The method is compared with the previously proposed pulse-based approaches, and the influence of the modulation frequency is further discussed.
- Published
- 2018
11. Diagnostic effectiveness of dermoscopy performed by plastic surgery registrars trained in melanoma diagnosis.
- Author
-
Pescarini E, De Antoni E, Azzena GP, Vindigni V, and Brambullo T
- Subjects
- Humans, Retrospective Studies, Clinical Competence, Dermoscopy education, Medical Staff, Hospital, Melanoma pathology, Melanoma surgery, Skin Neoplasms pathology, Skin Neoplasms surgery, Surgery, Plastic education
- Abstract
Background: Dermoscopy improves sensitivity and specificity and helps in the early detection of melanoma and nonmelanoma skin cancers (NMSC). Because of the multidisciplinary approach to melanoma, plastic surgeons may be required to perform dermoscopy evaluation. For this reason, in some university hospitals, plastic surgeons in training might perform these evaluations. To assess the validity of digital dermoscopy conducted by plastic surgery registrars, the authors collected the diagnoses of excised lesions from a dermoscopy outpatient clinic, comparing results with literature., Methods: A total of 1094 consecutive dermoscopy evaluations performed at Padova University Hospital between 2015 and 2018 were included in the study. All examinations were carried out by 3 plastic surgery registrars who received comparable training on dermoscopy. Excised lesions were classified according to pathological reports., Results: Four hundred sixty-six lesions were excised, and of them, 224 (48%) were considered pathological or atypical lesions: 34 melanomas (15%), 83 dysplastic or uncertain significance nevi (37%), and 107 NMSC and their precursors (48%). Considering only the 347 pigmented lesions, 34% were malignant or dysplastic lesions. The number needed to treat (NNT) was 10. The nevi-to-melanoma ratio (NMR) was 8, and the malignant melanoma-to-melanoma in situ ratio (MM:MMIS ratio) was 0.36., Conclusions: This retrospective study tested the performance of specifically trained plastic surgery registrars in the detection of malignant skin lesions. Compared to literature, the analysis reflects a good sensibility for melanoma, especially in early curable stages. Moreover, our study underlines quite a high number of total excisions, which could be explained by the "surgical imprinting" of plastic surgery registrars., Competing Interests: Declaration of Competing Interest None., (Copyright © 2019 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
12. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
- Author
-
Becquart O, Guillot B, Bourrain JL, Duflos C, and Du-Thanh A
- Subjects
- Carcinoma, Basal Cell chemically induced, Carcinoma, Squamous Cell chemically induced, Humans, Melanoma chemically induced, Risk Assessment, Hydrochlorothiazide adverse effects, Skin Neoplasms chemically induced
- Abstract
The risk of skin cancer induced by photosensiting drugs is well known. An association between hydrochlorothiazide use and skin cancer has been recently published in some epidemiological studies. A systematic review of case-control or prospectives cohorts showed an increased risk of cutaneous squamous cell carcinoma even if some confusing factors such as tobacco smoking was not analysed. Results are more conflicting for basal cell carcinoma or melanoma. These results do not modify the benefit/risk ratio but should lead to propose preventive mesures: identification of high risk population, avoidance of this drug if possible in immunocompromised patients or with previous skin cancer, regular skin examination in case of long term use of hydrochlorothiazide., (Copyright © 2019 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
13. Posttransplantation cutaneous B-cell lymphoma with monoclonal Epstein-Barr virus infection, responding to acyclovir and reduction in immunosuppression
- Abstract
Posttransplantation lymphoproliferative disorders (PTLDs) represent an important complication of solid organ transplantation. The main causative factor of PTLDs seems to be the intensity and type of immunosuppressive therapy and the frequent occurrence of Epstein-Barr virus infection. PTLDs that are disseminated at diagnosis or present late after transplantation generally share an unfavorable prognosis and are unlikely to regress in response to reduction in immunosuppressive therapy. We describe a case of cutaneous B-cell lymphoma occurring 4 years after heart transplantation in which molecular analysis revealed a monoclonal pattern of Epstein-Barr virus infection and immunoglobulin gene rearrangement. In spite of its monoclonal nature and late occurrence, the lymphomatous lesions regressed completely after antiviral treatment and a reduction in immunosuppressive therapy.
- Published
- 1997
14. Radiotherapy of cutaneous B cell lymphomas: our experience in 31 cases
- Author
-
Emilio Berti, Roberta Piccinno, Luca Baldini, Massimo Caccialanza, Piccinno, R, Caccialanza, M, Berti, E, and Baldini, L
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Skin Neoplasms ,Lymphoma, B-Cell ,medicine.medical_treatment ,Cutaneous B-cell lymphoma ,Malignancy ,Follow-Up Studie ,Medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Skin Neoplasm ,Stage (cooking) ,B-cell lymphoma ,Lymph node ,Aged ,Aged, 80 and over ,Chemotherapy ,Radiation ,business.industry ,Remission Induction ,Middle Aged ,medicine.disease ,Peripheral T-cell lymphoma ,Surgery ,Radiation therapy ,medicine.anatomical_structure ,Oncology ,Female ,Radiology ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies ,Human - Abstract
Purpose: Since cutaneous B cell lymphomas belong mostly to low or intermediate histologic grade of malignancy and have low tendency to spreading, a local treatment such as radiotherapy appears to be a suitable choice in the management of the disease. The authors have reviewed their cases to verify this statement. Methods and Materials: 31 patients affected by cutaneous B cell lymphomas classified as IE stage according to Ann Arbor received radiotherapy with orthovoltage techniques with total doses per field ranging from 10 to 40 Gy (median dose 30 Gy). All the patients had a minimum follow-up of 2 years. Results: All the target skin lesions underwent complete remission. In 10 patients (32.2%) the clinical remission is still lasting. In 21 cases (67.8%) a disease relapse was observed: only at skin in other sites than those previously treated in 17 (81%), at skin and lymph nodes in two cases (9.5%), at skin, bone, and lymph node in one case (4.7%), at skin and bowel in one case (4.7%). The extracutaneous involvement occurred in cases with lesions of intermediate grade malignancy. After a new course of radiotherapy for skin lesions only, and chemotherapy, surgery or megavoltage radiotherapy for the other involvements, on the whole 21 patients (67.8%) got a complete remission. Conclusion: On the basis of their results and of a review of the literature, the authors propose radiotherapy as the choice treatment of primary cutaneous B cell lymphomas.
- Published
- 1993
15. Delta chain-positive T-cell lymphoma of the skin
- Abstract
Cutaneous T-cell lymphomas (CTCL) represent a heterogeneous group with respect to clinical presentation, histology, and phenotype. The most frequent CTCL represent a proliferation of x/x+ T-cell with a helper inducer memory phenotype (CD4+, CD29+, CD45RO+)
- Published
- 1994
16. Radiotherapy of cutaneous B cell lymphomas: our experience in 31 cases
- Abstract
Purpose: Since cutaneous B cell lymphomas belong mostly to low or intermediate histologic grade of malignancy and have low tendency to spreading, a local treatment such as radiotherapy appears to be a suitable choice in the management of the disease. The authors have reviewed their cases to verify this statement. Methods and Materials: 31 patients affected by cutaneous B cell lymphomas classified as IE stage according to Ann Arbor received radiotherapy with orthovoltage techniques with total doses per field ranging from 10 to 40 Gy (median dose 30 Gy). All the patients had a minimum follow-up of 2 years. Results: All the target skin lesions underwent complete remission. In 10 patients (32.2%) the clinical remission is still lasting. In 21 cases (67.8%) a disease relapse was observed: only at skin in other sites than those previously treated in 17 (81%), at skin and lymph nodes in two cases (9.5%), at skin, bone, and lymph node in one case (4.7%), at skin and bowel in one case (4.7%). The extracutaneous involvement occurred in cases with lesions of intermediate grade malignancy. After a new course of radiotherapy for skin lesions only, and chemotherapy, surgery or megavoltage radiotherapy for the other involvements, on the whole 21 patients (67.8%) got a complete remission. Conclusion: On the basis of their results and of a review of the literature, the authors propose radiotherapy as the choice treatment of primary cutaneous B cell lymphomas
- Published
- 1993
17. Liquid nitrogen for the treatment of actinic keratosis: a longitudinal assessment.
- Author
-
Ianhez M, Miot HA, and Bagatin E
- Subjects
- Aged, Female, Humans, Longitudinal Studies, Male, Middle Aged, Sunscreening Agents therapeutic use, Treatment Outcome, Cryosurgery methods, Keratosis, Actinic surgery, Nitrogen therapeutic use
- Abstract
Cryosurgery with liquid nitrogen is one of the most used treatments for actinic keratosis. We aimed to study the effectiveness of two consecutive sessions of cryosurgery for actinic keratosis and investigate factors associated with its therapeutic success. Hence, we conducted a longitudinal study including 92 patients of both sexes, aged 50-75 years with 5-50 actinic keratosis on the face and forearms, who underwent cryosurgery and treatment with sunscreen SPF 30, at baseline and after 120 days. The lesions were counted in duplicate by the same examiner before the start of treatment and after 120 (N=92) and 300 days (N=33), represented by their medians and quartiles and compared using the generalized linear mixed effects model (negative binomial). Treatment behavior was investigated in relation to sex, age, education, skin type, smoking, sun exposure at work and the use of aspirin, anti-inflammatory and angiotensin-converting enzyme inhibitors. There was a significant reduction in the actinic keratosis count on the face and forearms (p<0.05). Our results confirmed the effectiveness of cryosurgery for actinic keratosis, with a 57% reduction in the number, and size of the lesions. Higher education levels (p=0.02) and less sun exposure at work (p=0.02) independently promoted a significant reduction in the actinic keratosis count. Different population groups showed characteristic responses to the treatment, which may be explained by the degree of adherence to the use of photoprotection. In two sessions, cryosurgery with liquid nitrogen reduced the actinic keratosis count., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
18. Malignancy in chronic burn scar: a 20 year experience in Mosul-Iraq.
- Author
-
Al-Zacko SM
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Carcinoma, Squamous Cell etiology, Chronic Disease, Female, Humans, Iraq, Male, Middle Aged, Neoplasm Recurrence, Local, Skin Neoplasms etiology, Young Adult, Burns complications, Carcinoma, Squamous Cell epidemiology, Cicatrix, Hypertrophic complications, Skin Neoplasms epidemiology
- Abstract
Background: Marjolin's ulcer, a term used to describe a malignancy arising in chronic ulcers of the skin, sinuses, scar tissue, and especially burns scars. The majority of burn scar carcinomas are seen after a lag period in burns that were not grafted following injury., Objective: To describe the epidemiology and its clinical characteristics of patients with Marjolin's ulcer arising in a chronic burn scar., Design and Patients: A case series study was done at Al-Jumhoori Teaching Hospital Burn Center, identifying 27 patients with chronic burn scar that underwent malignant transformation into a carcinoma, from January 1992 to December 2011. Data related to patients were retrieved from their medical records. All lesions were secondary to burns from various causes. All patients were proven to have malignancy by biopsy., Results: Of the 27 Marjolin's ulcer patients, 18 were males and 9 were female (male to female ratio 2:1), and the mean age was 42.7 years (range: 18-80 years). Upon histological examination, all were diagnosed as well-differentiated squamous cell carcinoma. The lower limb was most frequently affected (81.5%). Treatment of the neoplasm consisted of excision and grafting in 81.5%, radiotherapy in 11.1% and amputation in 7.4%. Local recurrence was noted in 22.2%, and lymph node metastasis in 11.1%., Conclusion: Chronic ulcer that undergoes malignant change was a common finding in the present study. All suspected masses or ulcers within chronic burn scars should be promptly biopsied., (Copyright © 2013 Elsevier Ltd and ISBI. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
19. Primary cutaneous melanoma: an 18-year study.
- Author
-
Anger M, Friedhofer H, Fukutaki MF, Ferreira MC, and Landman G
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Brazil epidemiology, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Mitotic Index, Prognosis, Retrospective Studies, Young Adult, Melanoma epidemiology, Melanoma pathology, Neoplasms, Radiation-Induced epidemiology, Neoplasms, Radiation-Induced pathology, Skin Neoplasms epidemiology, Skin Neoplasms pathology
- Abstract
Background: Primary cutaneous melanoma still constitutes the main cause of skin cancer death in developed countries, and its incidence in recent years has been increasing in a steady, worrisome manner., Objectives: This study evaluated the clinical, epidemiological and demographic aspects of this disease, and correlated them with patient prognosis., Methods: Using epidemiologic and clinical data, we analyzed 84 patients with mild to severe primary cutaneous melanoma treated between 1990 and 2007. Slides containing surgical specimens were analyzed, and new slides were made from archived paraffin sections when necessary., Results: The melanoma incidence was higher in areas of sun exposure, with lesions commonly observed in the trunk for males, and lower limbs for females. In addition to Breslow's thickness and ulceration (p = 0.043 and p < 0.001, respectively), the mitotic rate per mm(2) also correlated with worse patient outcome (p = 0.0007). The sum of ulceration (0 when absent or 1 when present), the Breslow index (1 when <1 mm, 2 when >1 mm and <4 mm, 3 when >4 mm) and the mitotic index (0 when absent or 1 when > or =1 per mm(2)) allowed the establishment of a prognostic score: if the sum was equal to or over three, nearly all (91.7%) patients had systemic disease. The 5-year survival was approximately seventy percent., Conclusion: Because American Join Committee of Cancer Staging will update the classification of malignant tumors (TNM) staging in the near future, and introduce mitosis as a prognostic factor, our results show the importance of such a feature. Additional studies are necessary to confirm the importance of a prognostic score as proposed herein.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.